Catalyst Wire Dossier Catalyst Wire Dossier

Bismuth quadruple therapy containing cefuroxime and tetracycline

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Bismuth quadruple therapy containing cefuroxime and tetracycline, covering 2024-04-08 to 2024-04-08. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Bismuth Quadruple Therapy Containing Cefuroxime and Tetracycline as First-line Therapy for Eradicating Helicobacter Pylori in Patients Allergic to Penicillin [Phase 4]

See pricing